Cytrx reported $6.18M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Bioline Rx BLRX:US USD 57.94M 13.84M
Brainstorm Cell Therapeutics BCLI:US USD 7.5M 5.3M
Celldex Therapeutics CLDX:US USD 317.69M 16.91M
Curis CRIS:US USD 92.12M 13.6M
Cytrx CYTR:US USD 6.18M 2.1M
Glaxosmithkline GSK:US GBP 20.77B 520M
Karyopharm Therapeutics KPTI:US USD 356.48M 133.8M
Northwest Biotherapeutics NWBO:US USD 11.76M 4.59M
Novartis NVS:US USD 36.91B 44M
Roche Holding ROG:VX 33.82B 3.5B
Seattle Genetics SGEN:US USD 2.8B 42.91M
Takeda 4502:JP JPY 2.6T 149.67B